Myovant Sciences Announces European Commission Approval for RYEQO® for the Treatment of Women With Uterine Fibroids

  • RYEQO is the first and only once-daily long-term treatment for uterine fibroids in Europe
  • Indication has no limitation for duration of use, as supported by safety and efficacy data … Read full article

Leave a comment

Your email address will not be published. Required fields are marked *